Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort

1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi: 10.1016/S0140-6736(12)60240-2 22579043

2. World Health Organization. Global status report on noncommunicable diseases 2010: description of the global burden of NCDs, their risk factors and determinants. Geneva: World Health Organization; 2011 [cited 2011 Dec 22]. Available from: http://www.who.int/nmh/publications/ncd_report2010/en/.

3. Rashid M, Kwok CS, Gale CP, Doherty P, Olier I, Sperrin M, et al. Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure and cerebrovascular accident: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2017;3(1):20–36. doi: 10.1093/ehjqcco/qcw025 28927187

4. Fox K, Steg P, Eagle K, Goodman S, Anderson F, Granger C, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA. 2007;297(17):1892–900. doi: 10.1001/jama.297.17.1892 17473299

5. Alzuhairi K, Søgaard P, Ravkilde J, Gislason G, Køber L, Torp-Pedersen C. Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978–2012). Eur Heart J Qual Care Clin Outcomes. 2015;1:72–8.

6. Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323–35. doi: 10.1016/S0140-6736(16)32381-9 28236464

7. Collerton J, Jagger C, Yadegarfar ME, Davies K, Parker SG, Robinson L, et al. Deconstructing complex multimorbidity in the very old: findings from the Newcastle 85+ Study. BioMed Res Int. 2016;2016:8745670. doi: 10.1155/2016/8745670 26885519

8. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–9. doi: 10.1016/j.arr.2011.03.003 21402176

9. Norhammar A, Lindbäck J, Rydén L, Wallentin L, Stenestrand U. Improved but still high short-and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart. 2007;93(12):1577–83. doi: 10.1136/hrt.2006.097956 17237125

10. Alabas O, Hall M, Dondo T, Rutherford MJ, Timmis A, Batin P, et al. Long term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. J Epidemiol Community Health. 2017;71:25–32. doi: 10.1136/jech-2016-207402 27307468

11. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009;11(3):292–8. doi: 10.1093/eurjhf/hfp001 19176539

12. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007;99(5):636–41. doi: 10.1016/j.amjcard.2006.09.112 17317363

13. Lazzeri C, Valente S, Attanà P, Chiostri M, Picariello C, Gensini GF. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty. Eur J Prev Cardiol. 2013;20(3):392–8. doi: 10.1177/1741826711428243 22023803

14. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–75. doi: 10.1378/chest.128.4.2068 16236856

15. Kjøller E, Køber L, Iversen K, Torp‐Pedersen C. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail. 2004;6(1):71–7. doi: 10.1016/j.ejheart.2003.09.008 15012921

16. Juillière Y, Cambou JP, Bataille V, Mulak G, Galinier M, Gibelin P, et al. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry. Rev Esp Cardiol (Engl Ed). 2012;65(4):326–33.

17. Lazzeri C, Valente S, Chiostri M, Attana P, Mattesini A, Dini CS, et al. Comorbidities in STEMI patients submitted to primary PCI: temporal trends and impact on mortality: a 6-year single center experience. Int J Cardiol. 2013;167(6):3042–4. doi: 10.1016/j.ijcard.2012.11.091 23200270

18. Chen H-Y, Saczynski JS, McManus DD, Lessard DM, Yarzebski JL, Lapane KL, et al. The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective. Clin Epidemiol. 2013;5:439–48. doi: 10.2147/CLEP.S49485 24235847

19. Gili M, Sala J, Lopez J, Carrion A, Bejar L, Moreno J, et al. [Impact of comorbidities on in-hospital mortality from acute myocardial infarction, 2003–2009.] Rev Esp Cardiol. 2011;64(12):1130–7. doi: 10.1016/j.recesp.2011.07.010 22018686

20. Sanchis J, Nunez J, Bodi V, Nunez E, Garcia-Alvarez A, Bonanad C, et al. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin Proc. 2011;86(4):291–6. doi: 10.4065/mcp.2010.0702 21346247

21. Schelde AB, Schmidt M, Madsen M, Petersen KL, Nielsen SS, Frokiar J, et al. Impact of co-morbidity on the risk of first-time myocardial infarction, stroke, or death after single-photon emission computed tomography myocardial perfusion imaging. Am J Cardiol. 2014;114(4):510–5. doi: 10.1016/j.amjcard.2014.05.031 25015696

22. Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sørensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012;344:e356. doi: 10.1136/bmj.e356 22279115

23. McManus DD, Nguyen HL, Saczynski JS, Tisminetzky M, Bourell P, Goldberg RJ. Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990–2007) and impact on death rates at 30 days and 1 year. Clin Epidemiol. 2012;4:115–23. doi: 10.2147/CLEP.S30883 22701091

24. Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52–60. doi: 10.1001/jama.2015.7008 26151266

25. Hagenaars JA, McCutcheon AL. Applied latent class analysis. Cambridge: Cambridge University Press; 2002.

26. National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. London: National Institute for Health and Care Excellence; 2016 [cited 2018 Jan 10]. Available from: https://www.nice.org.uk/guidance/NG56.

27. Hall M, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, et al. Association of clinical factors and therapeutic strategies with improvements in survival following non–ST-elevation myocardial infarction, 2003–2013. JAMA. 2016;316(10):1073–82. doi: 10.1001/jama.2016.10766 27574717

28. Herrett E, Smeeth L, Walker L, Weston C. The Myocardial Ischaemia National Audit Project (MINAP). Heart. 2010;96(16):1264–7. doi: 10.1136/hrt.2009.192328 20659944

29. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi: 10.1093/eurheartj/ehv320 26320110

30. National Institute for Health and Care Excellence. Unstable angina and NSTEMI: early management. London: National Institute for Health and Care Excellence; 2013 [cited 2015 Jul 13]. Available from: http://www.nice.org.uk/guidance/CG94.

31. Ministry of Housing, Communities & Local Government. English indices of deprivation 2010. London: Ministry of Housing, Communities & Local Government; 2011 [cited 2018 Jan 10]. Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010.

32. Royston P, Lambert PC. Flexible parametric survival analysis using Stata: beyond the Cox model. College Station (Texas): Stata Press; 2011.

33. Dondo T, Hall M, Timmis A, Gilthorpe M, Alabas O, Batin P, et al. Excess mortality and guideline-indicated care following non ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2016;6(5):412–20. doi: 10.1177/2048872616647705 27142174

34. Andersson TML, Dickman PW, Eloranta S, Lambe M, Lambert PC. Estimating the loss in expectation of life due to cancer using flexible parametric survival models. Stat Med. 2013;32(30):5286–300. doi: 10.1002/sim.5943 24038155

35. Government Actuary’s Department. Interim life tables of mortality rates for England and Wales. London: Government Actuary’s Department; 2014.

36. Cattle B, Baxter P, Greenwood D, Gale C, West R. Multiple imputation for completion of a national clinical audit dataset. Stat Med. 2011;30(22):2736–53. doi: 10.1002/sim.4314 21786284

37. Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581–92.

38. Alfredsson J, Alexander KP. Multiple chronic conditions in older adults with acute coronary syndromes. Clin Geriatr Med. 2016;32(2):291–303. doi: 10.1016/j.cger.2016.01.009 27113147

39. Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel J-P, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54. doi: 10.1016/S0140-6736(15)00516-4 26520231

40. British Heart Foundation. CVD statistics—BHF UK factsheet. Birmingham: British Heart Foundation; 2017 [cited 2018 Jan 12]. Available from: https://www.bhf.org.uk/-/media/files/research/heart-statistics/bhf-cvd-statistics—uk-factsheet.pdf?la=en.

41. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):434–41.

42. Asaria M, Walker S, Palmer S, Gale CP, Shah AD, Abrams KR, et al. Using electronic health records to predict costs and outcomes in stable coronary artery disease. Heart. 2016;102(10):755–62. doi: 10.1136/heartjnl-2015-308850 26864674

43. Walker S, Asaria M, Manca A, Palmer S, Gale CP, Shah AD, et al. Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER). Eur Heart J Qual Care Clin Outcomes. 2016;2(2):125–40. doi: 10.1093/ehjqcco/qcw003 27042338

44. Ertl G, Ruschitzka F. The year in cardiology 2013: heart failure. Eur Heart J. 2014;35(7):470–3. doi: 10.1093/eurheartj/eht555 24385377

45. Gho JM, Schmidt A, Koudstaal S, Pujades-Rodriguez M, Denaxas S, Gale C, et al. Heart failure following myocardial infarction: a cohort study of incidence and prognostic factors in 24 745 patients using linked electronic records. Eur J Heart Fail. 2016;18:442.

46. Lasko TA, Denny JC, Levy MA. Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data. PLoS ONE. 2013;8(6):e66341. doi: 10.1371/journal.pone.0066341 23826094

47. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. doi: 10.1016/S0140-6736(12)62167-9 23395245

48. Hall M, Alabas OA, Dondo TB, Jernberg T, Gale CP. Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes. Eur Heart J Qual Care Clin Outcomes. 2015;1(2):85–91.